Where to buy NAD+ (nicotinamide adenine dinucleotide) in the UK: the sellers with a verifiable COA
The newest verifiable NAD+ certificate on any UK seller's website is on Mercia Research (merciaresearch.com), analysed 15 Sep 2026 (task #231810 on Janoshik's site); 10 verified sellers hold one covering NAD+, listed newest first below.
A record of paperwork, not a recommendation: The Peptide Watch sells nothing, takes no money from sellers and links to none of them.
Who has the newest report · Why the date matters · What purity means · What NAD+ is · Regulators · Every report
Who holds the newest NAD+ report (10 verified UK sellers)
Newest report first. Every report was opened on Janoshik's own website and names the seller as the client. The date is the analysis date printed on the report. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Newest NAD+ report | Age of that report | Purity on it | |
|---|---|---|---|---|
| Mercia Research | 15 Sep 2026 | 25 days | amount only | verify |
| Biohackpeptides | 8 Sep 2026 | 1 month, 2 days | amount only | verify |
| Peptology Labs | 4 Sep 2026 | 1 month, 6 days | amount only | verify |
| Thoroughbredlabs | 18 Aug 2026 | 1 month, 22 days | amount only | verify |
| UKMAXX | 29 Jul 2026 | 2 months, 11 days | amount only | verify |
| Peptifyuk | 7 May 2026 | 5 months, 3 days | amount only | verify |
| Xlpeptides | 21 Apr 2026 | 5 months, 19 days | amount only | verify |
| Clinicore | 28 Jan 2026 | 8 months, 12 days | amount only | verify |
| Phoenixbiolabs | 29 Oct 2025 | 11 months, 11 days | amount only | verify |
| Kensingtonlabs | 9 Jul 2025 | 15 months, 1 day | amount only | verify |
Every NAD+ purity report we have read (11), one row per report
The 11 verifiable NAD+ certificates we have read, newest first
Each row was opened on Janoshik's own site by a real page load and transcribed. The client column is the name the laboratory printed; a certificate counts as a seller's own only when that name is the seller. The report date is the analysis date printed on the report where we have read it, otherwise the date the laboratory received the sample. The verify link opens the laboratory, never the shop. Audit findings, not recommendations.
| Seller | Task | Client on the report | Report date | Result | Batch | |
|---|---|---|---|---|---|---|
| Mercia Research | #231810 | Mercia Research Limited | 15 Sep 2026 | NAD+ · 345.68 mg/ml | MRL-26Q3-A07 | verify |
| Biohackpeptides | #227610 | BiohackPeptides.co.uk | 8 Sep 2026 | NAD+ · 573.71 mg | BHP26HNJ500 | verify |
| Peptology Labs | #229639 | PEPTOLOGY LABS LTD | 4 Sep 2026 | NAD+ · 467.99 mg | ND5106 | verify |
| Thoroughbredlabs | #222875 | Thoroughbred Labs | [email protected] | 18 Aug 2026 | NAD+ · 542.58 mg | TBLNA030 | verify |
| UKMAXX | #208698 | UKMAXX | 29 Jul 2026 | NAD+ · 568.26 mg | NAD-2026-05-A | verify |
| Peptifyuk | #149066 | Peptify UK | 7 May 2026 | NAD+ · 552.9 mg | 2026/04 | verify |
| Xlpeptides | #148205 | XL Peptides | 21 Apr 2026 | NAD+ · 516.3 mg | 07001 | verify |
| Clinicore | #103865 | clinicore | 28 Jan 2026 | NAD+ · 563.63 mg | nad500101 | verify |
| Phoenixbiolabs | #85381 | www.phoenixbiolabs.net | 29 Oct 2025 | NAD+ · 102.25 mg | 00086 | verify |
| Kensingtonlabs | #70797 | Kensington labs | 9 Jul 2025 | NAD+ · 115.51 mg | NAD-563LV | verify |
| Xlpeptides | #65256 | XL Peptides | 15 May 2025 | NAD+ · 553.93 mg | 007002 | verify |
Why the date on a certificate matters
What a purity figure means
The purity on a Janoshik report is the share of the main peak in an HPLC chromatogram. 99.5% means that 99.5% of what the detector saw was one substance and 0.5% was something else. It is not the amount in the vial: that is the separate quantity line, in milligrams. It does not by itself prove which substance the peak is: that is identity, confirmed by mass spectrometry. And it says nothing about sterility, endotoxins or heavy metals, which are separate tests.
A purity figure printed on a shop page with no report behind it is a claim, not a measurement. Between two reports, the difference that matters is rarely 99.2% against 99.8%; it is whether the report exists at all, names the seller as the client, covers this compound on its own, and is recent.
What NAD+ is, and what it is sold as
NAD+ is not a peptide at all but a coenzyme every living cell makes; UK research-peptide shops sell it as a powder for injection alongside their peptides. Because it degrades readily, a certificate that states the amount actually recovered from the vial matters more than the label.
| Development status | Never in clinical development. Never approved as a medicine in any country. The registered trials are almost all of oral precursors run by universities and hospitals. |
|---|---|
| Originator | A natural coenzyme present in every living cell; first described as a yeast cofactor in 1906. Rights: No rights holder; no company owns NAD+ as a molecule. |
| Registered clinical trials | 264 on ClinicalTrials.gov |
A coenzyme, not a peptide, with a literature that is mostly about its precursors. PubMed indexes 3,005 papers on NAD+ supplementation or infusion, 1,619 of them in rodents, and 69 clinical-trial reports; almost all of those trials gave oral precursors, nicotinamide riboside or nicotinamide mononucleotide, not NAD+ itself. ClinicalTrials.gov lists 264 registered trials on the same terms, again dominated by precursors.
Injected NAD+ has almost no controlled evidence and no licence anywhere. Trials of intravenous or subcutaneous NAD+ are few and small. No regulator has approved NAD+ as a medicine; UK drip clinics supply it as an unlicensed product, and in the United States it exists only as a compounded preparation.
What a certificate can tell you here. NAD+ degrades readily in solution and on storage, so the useful number on a report is the amount actually recovered. The reports we read recovered between 102 mg and 554 mg per vial across four sellers, which is why the figure, not the label, is what to read.
The published record in numbers, and the sources
| Papers on PubMed | 3005 |
|---|---|
| Indexed as rat or mouse studies | 1619 |
| Indexed as clinical trials | 69 |
| Published since 2020 | 1344 |
Counts are from PubMed on 15 September 2026 using the queries recorded in our evidence file. A description of the published record, not medical advice and not an argument for or against use.
- A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment. (Alzheimers Dement, 2026, PMID 42478598)
- NAD+ augmentation by nicotinamide riboside engages SLIT2/ROBO1 signaling to attenuate Th17 inflammation in psoriasis. (JCI Insight, 2026, PMID 42048163)
- Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial. (Nat Med, 2026, PMID 42056497)
- Association between blood nicotinamide adenine dinucleotide levels and blood laboratory parameters at baseline and after nicotinamide mononucleotide supplementation in middle-aged healthy individuals: post hoc analysis of a randomized, double-blinded, placebo-controlled clinical trial. (Geroscience, 2026, PMID 41162813)
- The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. (Adv Nutr, 2023, PMID 37619764)
- Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. (Am J Physiol Endocrinol Metab, 2024, PMID 37971292)
- The Promise of Niacin in Neurology. (Neurotherapeutics, 2023, PMID 37084148)
- ClinicalTrials.gov, registered studies of NAD+ or nicotinamide adenine dinucleotide
What regulators say about NAD+
In the UK. Not a licensed medicine in the UK; supplied by drip clinics as an unlicensed product and by research-chemical sellers as a powder.
We hold no statement from the FDA, MHRA or EMA specifically about NAD+ on file. Its development and licence sources are listed under the record above.
What the 11 NAD+ certificates show
We have read 11 Janoshik reports covering NAD+, published by 10 UK sellers. Each was opened on Janoshik's own website. All 11 name the seller itself as the client. 7 of the 11 are dated within the last six months and 2 are more than a year old. The newest is dated 15 Sep 2026 and the oldest 15 May 2025.
A certificate is a batch document. The lines that matter are the compound (it must say NAD+, not only a batch code), the client (the shop, not its supplier) and the analysis date. A new batch is untested until a new report appears.
NAD+ in the UK at a glance
| Active UK sellers listing NAD+ | 54 |
|---|---|
| Of which publish a verifiable own-name certificate | 11 |
| Of which name no laboratory at all | 21 |
Counted from the vendor ledger at build time. The A-Z directory lists every seller and what each publishes instead.
Questions people ask
Which UK sellers publish a verifiable Janoshik certificate naming NAD+?
As of 10 October 2026, 10: Mercia Research, Biohackpeptides, Peptology Labs, Thoroughbredlabs, UKMAXX, Peptifyuk, Xlpeptides, Clinicore, Phoenixbiolabs, Kensingtonlabs. Each has a report on Janoshik's own website that names the seller as the client and lists NAD+. That is a statement about paperwork, not a recommendation; The Peptide Watch does not recommend anywhere to buy NAD+.
How recent is the newest NAD+ certificate from a UK seller?
The newest we have read is Janoshik task #231810, analysed 15 Sep 2026. It is published by Mercia Research and names it as the client. A certificate covers one batch, so an old one says little about stock on sale today.
How do I check that a certificate for NAD+ is genuine?
Four things: an independent laboratory is named; the client field names the seller you are buying from, not a supplier; the compound line says NAD+; and the report's task number and key open the same report on the laboratory's own website (verify.janoshik.com). A branded PDF with no laboratory name and no verification code fails on the first check, however professional it looks. The free COA Checker on this site runs the checks for you.
Is NAD+ a licensed medicine in the UK?
Not a licensed medicine in the UK; supplied by drip clinics as an unlicensed product and by research-chemical sellers as a powder. Never approved as a medicine in any country. The registered trials are almost all of oral precursors run by universities and hospitals. The Peptide Watch does not give legal or medical advice.
Why does The Peptide Watch not say where to buy NAD+?
Because the site records paperwork, not recommendations. A verifiable certificate proves that a sample of one batch was tested. It does not prove the vial you receive matches it, and it says nothing about whether anyone should use NAD+. Listing which sellers publish a certificate you can check, and which publish nothing, is as far as the evidence goes.
The Peptide Watch's position on NAD+
Not a licensed medicine in the UK; supplied by drip clinics as an unlicensed product and by research-chemical sellers as a powder. The Peptide Watch reads the certificates UK sellers publish and does not recommend anywhere to buy NAD+. Sellers on this page are listed by the date of their newest NAD+ certificate and by nothing else. If you can verify a seller's testing, you can at least judge its evidence; if you cannot, you are taking the seller's word for what is in the vial. See how UK testing compares across every seller in the market statistics.
An honest note: a verifiable certificate proves a sample of a batch was tested, not that the specific vial you receive matches it, see what this can and can't tell you. The Peptide Watch sells no NAD+ and links to no shop; this is research-use-only information, not medical or dosing advice.
All peptides · Other compounds: BPC-157 · TB-500 · GHK-Cu · Ipamorelin · CJC-1295 · MOTS-c · Epithalon · Selank · Semax · Tesamorelin · Melanotan 2 · KPV · PT-141 · SS-31 · DSIP · Melanotan 1 · AOD-9604 · 5-Amino-1MQ · Glutathione · Kisspeptin · Thymosin Alpha-1 · GHRP-6 · HGH Fragment 176-191 · IGF-1 LR3 · FOXO4-DRI · Oxytocin · SLU-PP-332 · MK-677 · GLOW and KLOW blends · Sermorelin · GHRP-2 · Hexarelin · ARA-290 · AHK-Cu